Direct lending issuance by US private credit firms dropped to approximately $45 billion in Q2 2025, down from $75 billion in Q1, even as the sector raised $52 billion in new commitments during the same period. The divergence leaves an estimated $180 billion in dry powder across the asset class, the widest deployment gap since late 2020.

The decline reflects two structural shifts. First, private equity sponsors postponed planned exits and recapitalizations as public equity multiples compressed in April and May, reducing deal flow into the direct lending pipeline. Second, borrowers who locked in leverage during 2023 and early 2024 now carry enough covenant cushion to avoid refinancing into higher rates. Roughly 62% of outstanding direct loans mature after 2027, insulating near-term deployment from what would otherwise be natural rollover activity.

This matters because private credit's growth thesis depends on continuous deployment at returns that justify 12-14% net IRRs to limited partners. Funds sitting on capital for more than two quarters begin paying management fees on undeployed commitments, eroding net returns and creating pressure to chase marginal credits. The last time the sector faced a similar deployment lag—Q4 2022 into Q1 2023—default rates on middle-market loans climbed 190 basis points within six months as managers relaxed underwriting to meet deployment targets.

Meanwhile, the $20 billion in Q1 redemption requests reported separately this week suggests that some allocators are already pulling forward liquidity ahead of anticipated fund performance deterioration. Those redemptions are being met through secondary sales at discounts between 4-7% to NAV, which creates mark tension for funds still valuing portfolios at par. If deployment continues lagging while redemption queues lengthen, the sector faces a valuation reset that will surface in Q3 and Q4 reported NAVs.

Allocators should track three follow-on signals through August. First, whether Ares, Blue Owl, and Blackstone deploy at least $15 billion combined in Q3—failure to hit that threshold indicates the pipeline remains shallow. Second, whether EBITDA covenant cushions on existing borrowers tighten below 1.2x—a sign that operating performance is deteriorating and sponsors may need rescue financing. Third, whether fund-level leverage at BDCs creeps above 1.15x statutory limits, forcing asset sales into a thin secondary market.

The deployment gap is no longer a timing mismatch. It is becoming a structural feature of a sector that grew faster than the deal market could absorb.